Editorial


Total quality management and accreditation In Iraq


Global launch of Child Watch

The health and social needs of children in impoverished areas


Clinical features and prognostic factors of breast cancer at Jordan


Clinical Study of Childhood Brucellosis in Jordan


Incidence of hyperkalemia in patients of type 1 and type 2 diabetes mellitus in Saudi Arabia

 


Abdulrazak Abyad
MD, MPH, MBA, AGSF, AFCHSE

Editorial office:
Abyad Medical Center & Middle East Longevity Institute
Azmi Street, Abdo Center,
PO BOX 618
Tripoli, Lebanon

Phone: (961) 6-443684
Fax:     (961) 6-443685
Email:
aabyad@cyberia.net.lb

 
 

Lesley Pocock
medi+WORLD International
572 Burwood Road,
Hawthorn 3122
AUSTRALIA
Emai
l
: lesleypocock

 


Clinical study of childhood brucellosis in Jordan

 
AUTHORS

Sami M Magableh MD
Hussein A Bataineh MD

From the pediatric department at Prince Rashed Hospital (PRH) 2006.

CORRESPONDENCE

Dr Hussein Bataineh
PO Box: 260, Aidoun 21166, Irbid, Jordan
Tel: 00962777243881
Fax: 0096227100797
Email: Hussein_azzam@yahoo.com


ABSTRACT

Objective: The present study was carried out to obtain the prevalence of childhood brucellosis among patients attending the pediatric department at PRH.

Material and Methods: A total of 5726 blood specimens (from children aged 14 years and younger) were studied for the serological evidence of brucellosis.

Results: Ninety-three (1.6 per cent) showed diagnostic agglutinin titres. Forty-three (59.7 per cent) blood specimens yielded the growth of Brucella melitensis. Thirty-nine patients (41.93 per cent) were shepherds. More than 60 per cent of the patients had a history of both consumption of fresh goat's milk and close animal contact. Seventy-three (78.49 per cent) were males and 20 (21.51 per cent) were females, with a male to female ratio of 3:1. The disease occurred mainly in the school age group (mean age 10.3 years). All the patients had an acute history of less than 2 months. Forty-nine (52.68 per cent) patients presented with persistent fever, 19 (20.43 per cent) with joint pain. Pityriasis Alba was the consistent physical finding, with fever in the majority of the patients. The major joint found to be involved was the knee (52.77 per cent). Eight patients presented with complications. In 15 cases (16.13 per cent) brucellosis was suspected clinically whereas 78 (83.87 per cent) cases, only serological evidence of brucellosis confirmed the diagnosis. None of the cases relapsed. In our experience an initial combination therapy two-drug regimen for a minimum of 6 weeks was given.

Conclusion: In our series, pediatric brucellosis is quite common since this area is endemic to B. melitensis where a strong clinical suspicion or laboratory routine screening has to be done to diagnose and institute specific therapy.

Key Words: prevalence, brucellosis.

INTRODUCTION

Brucellosis constitutes a major health and economic problem in many parts of the world, including countries of the Mediterranean Basin, the Middle East and the Arabian Gulf.1, 2. It remains an uncontrolled problem in regions of high endemicity such as the Mediterranean, Middle East, Africa, Latin America and parts of Asia.3, 4.
Humans are infected accidentally by close animal contact or consumption of animal products infected by bacteria of the genus Brucella.5 Six species are recognized, and four are well-established human pathogens. Human infection can occur through consumption of infected raw milk, raw milk products, or raw meat.6 Other means of infection include skin abrasions 7 or inhalation of airborne animal manure particles.8 Brucellosis can affect any age including children. The incidence of childhood brucellosis varies. Some authors have concluded that brucellosis in children is rare.9
Brucellosis is an endemic disease in Jordan as evidenced by a marked increase in the number of reported cases by the Jordanian Ministry of Health.10, 11
Brucellosis, especially related to Brucella abortus is not frequent in children.12 in endemic B. melitensis areas; children represent 20-25 per cent of cases.13 The present study was carried out to obtain the prevalence of childhood brucellosis among patients attending PRH for clinical profile determination.

MATERIALS & METHODS

During the period from August 1996 to September 2006, all 5726 serum samples referred to the microbiology laboratory were examined for evidence of brucellosis. All the sera were screened for B. agglutinins by slide agglutination test using B. abortus colored antigen. The positive samples (97) found with the slide method, were analysed further for the levels of antibodies by standard tube agglutination employing B. abortus-plain antigen. Of the 93 blood specimens' positive for diagnostic titres (160), blood cultures were carried out in 72 cases. The blood specimens were inoculated onto two Castaneda's biphasic media consisting of trypticase soy agar and broth. The media were incubated at 37°C with and without CO2 for 1 month. The slide agglutination test was performed using B. abortus and B. melitensis monospecific antisera.

The tube agglutination test, with the help of same antisera, was also carried out wherever it was indicated. The antisera were obtained from Murex Biotech Ltd, Dartford, England.

The synovial fluid and CSF specimens were also subjected for B. agglutinins demonstration with both slide and tube tests as mentioned above. Additional specimens such as synovial fluid, CSF, and skin were cultured using the above techniques. A detailed clinical history including epidemiological features and examination findings were recorded and analysed.

 
RESULTS

Of the 5726 serum samples studied, 93 (1.6 per cent) demonstrated B. agglutinins in diagnostic titres. The titres ranged between 160 and 5120, (Table 1). Forty-three blood specimens (59 per cent) grew B. melitensis; 42 were biotype 1 and one isolate was biotype 3. Shepherds (39 patients) were the major occupational group affected in the present study. Of the 93 patients, 58 gave a history of both animal contact and raw milk ingestion. Males (73 patients) were predominant in our study with a male to female ratio of 3:1 (Table 2). The major age group affected was 11-14 years, followed by 6-10 years (Table 2).

The youngest age recorded with brucellosis was 33 months, a female child who had a history of raw milk ingestion. The patients presented with fever, joint pain, and low backache; fever being the main presentation (Table 3). One patient had involuntary movements of limbs alone and one presented with burning feet only. Pityriasis Alba was the consistent physical finding, with fever in the majority of patients.

Hepatosplenomegaly was noticed in 48 patients, splenomegaly alone in nine, and hepatomegaly alone in five patients. Single joint involvement was found in 29 patients, the knee joint (19 patients) being the major joint affected (Table 4). Successful isolation of B. melitensis was possible in knee joint synovial fluid of three out of five patients attempted. Two joints were affected in four patients and three patients showed involvement of three joints.

Eight patients presented with complications that included papular skin lesions (3), carditis (2), chorea (1), meningitis (1), and peripheral neuritis (1) (Table 5).

DISCUSSION

The prevalence of brucellosis in the present study was 1.6 per cent (93 children), which is much higher than the reports of Spink5 and Cucullu.9

Pediatric brucellosis is uncommon where B. abortus is endemic.12 However, in areas where B. melitensis is endemic, pediatric cases are seen14-17 in endemic B. melitensis areas, children represent 20-25 per cent of the cases.13

In the present study, 93 (19.1 per cent) children out of 485 cases were diagnosed as having brucellosis during a period from 1996 to 2006. This finding is similar to the data obtained from the Middle East countries, 14-17 although lower figures have been quoted by Dalrymple-Champney 18 from England. The high prevalence of childhood brucellosis in the present series can be attributed to the endemicity of this area for B. melitensis. The isolation of only B. melitensis species supported this fact. All the 73 patients, including 32 children with brucellosis, were due to B. melitensis in Israel16 and B. melitensis remains the principal cause of human brucellosis 19

The vehicle of transmission in most of the cases in the present study was the consumption of raw milk. Like that based on the findings of our study, we conclude that the main risk factor for brucellosis is consumption of fresh, unpasteurized dairy produce.20

The studies from Saudi Arabia, 21, 22 Iran, 23 and Spain 24 report that raw milk ingestion is an important factor in disease transmission. This finding may also be the reason for our cases showing predominance in school-aged children. These children may consume raw milk while tending the flock in their spare time. Children younger than 5 years had the least infection, and this has also been reported in literature.25-28
Human brucellosis usually manifests as an acute or sub acute febrile illness, which may persist, and progress to a chronically incapacitating disease with severe complications.29 In the present study; only 15 cases (16.13 per cent) were suspected of having brucellosis, showing that the disease awareness in an endemic area is important to arrive at a clinical diagnosis like Al-Shamahy et al in which: "If clinicians are made more aware of the presenting features of brucellosis and that it should come into the differential diagnosis of fever associated with enlarged liver, spleen and lymph nodes, it will lead to an increasing index of suspicion for this infection".30
In the present series, 78 cases (83.87 per cent) on admission were classified as enteric fever, malaria, pyrexia of unknown origin, and rheumatoid arthritis, showing the protean manifestations of brucellosis and necessitating collaboration between clinician and microbiologist even in endemic areas for the diagnosis of brucellosis. So: Brucellosis should be suspected and investigated for, in any case of pyrexia of unknown origin.31

The main clinical presentation of brucellosis in children is fever, but the skeletal manifestations of the disease are also significant.23 Fever was the commonest complaint in the present study and it is worth mentioning the joint pain, which was the only complaint in 19 patients. Fever and pityriasis Alba were a common association in the present series as ; In a prospective study in Jordan, fever (88%) was the most common clinical feature encountered, followed by sweating, arthralgia and general weakness. 32 and as that in Japan in which: Fever, arthritis or arthralgia, hepatomegaly and splenomegaly were the main findings.33

Monoarticular arthritis of the knee is the most frequent reported form, 14, 15, 34 which was observed in 19 patients in the present series.

Skin lesions are an uncommon feature of brucellosis.5, 35-38 All three patients with skin lesions in the present series had papules. To our knowledge, ours is the fourth report of bacteriologically confirmed skin lesions in brucellosis in the world. The skin lesions disappeared within 8-10 days of the start of antibiotic therapy. Neurological manifestations of brucellar origin although reported, have not documented chorea as a symptom in the world literature. One patient had brucellar chorea that was successfully treated. Brucellar meningitis reported in the present series received successful treatment. Relapse was not recorded in any of the cases. In our experience combination therapy with a minimum of two drugs and extending treatment for at least 6 weeks with two drugs seems warranted to improve outcome and prevent relapses like in Henk et al: The standard treatment of uncomplicated cases in adults and children 8 years of age and older is 100 mg doxycycline twice a day for 6 weeks plus 1 g. streptomycin daily for 2 to 3 weeks. Instead of streptomycin, rifampicin may be given in combination with doxycycline (200 mg/day orally for 6 weeks) at a dose of 600-900 mg for 6 weeks.39 In our series, pediatric brucellosis is quite common since this area is endemic to B. melitensis where a strong clinical suspicion or laboratory routine screening has to be done to diagnose and institute specific therapy. Similar to Issa H et al 1n 1999 in south of Jordan "Brucella agglutination test and titer in association with a suggestive clinical picture was more sensitive than blood culture in the diagnosis of brucellosis".40

 

 

Table 1. Antibody profile and culture status

Titre       Number positive     Number culture done    Culture positive

160                      37                               24                          15

320                      23                               19                          08

640                      10                               10                          07

1280                    15                               15                          09

2560                   04                               02                           02

5120                   04                               02                           02

Total                   93                              72                            43

back to text

Table 2. Age and sex distribution of 93 patients

Age (years)                      Male           Female                Total

0–5                                    02                  01                    03

6–10                                  24                  08                    32

11–14                                47                  11                    58

Total                                  73 (78.49%) 20 (21.5%)       93

back to text

Table 3. Clinical profile of 93 patients

Clinical presentation                  No. of patients                    % of patients

Fever                                                    49                                          52.68

Joint pain                                             19                                          20.43

Fever, joint pain & low backache 03                                         3.2

Fever and joint pain                            14                                           15.05

Fever and low backache                    06                                           06.43

Jerky movements of limbs                 01                                           01.07

Burning feet                                          01                                           01.07

Splenomegaly                                       09                                           09.67

Hepatomegaly                                       05                                           05.37

Hepatosplenomegaly                          48                                           51.61

back to text

Table 4. Involvement of joints

Joint(s)                                    No. of patients             % of patients

Knee                                         19                                   52.77

Hip                                             07                                  19.4

Shoulder                                   01                                  02.7

Ankle                                          02                                  05.5

Knee and elbow                       01                                  02.7

Knee and hip                            03                                   8.3

More than 2                               03                                   8.3

back to text

Table 5. Complications of brucellosis
Complication                             No. of  patients
Skin lesions                                03
Carditis                                         02
Chorea                                          01
Meningitis                                     01
Peripheral neuritis                      01
Total                                              08

back to text

 


 

REFERENCES

1. Matyas Z, Fujikura T. Brucellosis as a world problem. Dev Biol Stand 1984; 56:3-20.
2. Al-Eissa YA, Kambal AM, Al-Rabeeah AA, Abdullah AM, Al-Jurayyan NA, Al- Jishi NM. Osteoarticular brucellosis in children. Ann Rheum Dis 1990; 49:896-900.
3. Corbel MJ. Brucellosis: an overview. Emerg Infect Dis 1997; 3: 213-21.
4. Refai M. Incidence and control of brucellosis in the Near East region. Vet Microbiol 2002; 90: 81-110.
5. Spink WW. The Nature of Brucellosis. Minnesota University Press, Minnesota, 1956.
6. Foley BB, Clay MMO, Sullivan DJ.A study of brucellosis epidemic. Irish J Med Sci 1970; 3: 457-59.
7. Glass WI. Brucellosis as an occupational disease in New Zealand.NZ Med J 1964; 63: 301-3.
8. Williams E. Brucellosis and the British public. Lancet 1970; i: 1220-24.
9. Cucullu LM, De Arambaru FG, Daro DA. Sobre UN caso de brucellosis en la infan. Arch Argent de Pedia 1949; 31: 191.
10. Annual Reports of the Ministry of Health in Jordan, 1976-1987. Amman, Jordan, Ministry of Health, 1976-1987.
11. Annual Reports of the Ministry of Health in Jordan, 1988-1994. Amman Jordan, Ministry of Health, 1988-1994.
12. Hall WH. Modern chemotherapy for brucellosis in humans. Rev Infect Dis 1990; 12: 1060-99.
13. Brurgio R. Brucellosis. In: Ginebra JD (ed.), Tratado de las Enfermeda des Infecciosas en la Infancia, Barcelona Editorial CientficoMedico 1962; Vol. II: 873-900.
14. Sharda DC, Lubani MM. A study of brucellosis in childhood. Clinical Pediatr 1986; 25: 492-95.
15. Lubani MM, Dudin KI, Sharda DC, et al. A multicentre therapeutic study of 1100 children with brucellosis. Pediatr Infect Dis J 1989; 8: 75-8.
16. Yinnon AM, Morali GA, Goren A, et al. Effect of age and duration of disease on the clinical manifestations of brucellosis-A study of 73 consecutive patients in Israel.Isr J Med Sci 1993; 1: 11-16.
17. Tohme A, Hammoud A, el Rassi B, Germanos-Haddad M, Ghayad E. Human brucellosis Retrospective studies of 63 cases in Lebanon. Presse Med 2001; 30: 1339-43.
18. Dalrymple-Champneys SW. Undulant fever-neglected problem.Lancet 1950; i: 429.
19. 1st International Conference on Emerging Zoonoses Jerusalem, Israel. Brucellosis: An Overview. Emerging Infectious Diseases 1997; 3:213-221.
20. Cetinkaya Z, Aktepe OC, Ciftci IH, Demirel R.Seroprevalence of Human Brucellosis in a RuralArea of Western Anatolia, Turkey. J HEALTH POPUL NUTR 2005; 23(2):137-141.
21. Al-Eissa YA, Kambal AM, al-Nasser MN, et al. Childhood brucellosis - a study of 102 cases. Pediatr Infect Dis J 1990; 2: 74-9.
22. El-Amin EO, George L, Kutty NK, et al. Brucellosis in children of Dhofar region, Oman. Saudi Med J 2001; 22(7): 610-15.
23. Makarem Eh, Karjoo RK, Omidi A. Frequency of Brucella melitensis in southern Iran. Trop Pediatr 1982; 28: 97.
24. Colmenro JD, Valdivielso P, Camp MI, et al. Brucellosis: estudio clinico epidemiologico de 139 casos. Med Clin (Barc) 1983; 80:748-751
25. Gotuzzo E,Carillo C,Seas C,et al.Caracteristicas epidemiologicasy clinicas de la brucellosis en 39 groups familiares.Rev Esp Enterm Infecc Microbiol Clin1987;7:519-23.
26. Black RA. Brucella-melitensis meningitis in an infant. Arch Pediatr 1937; 54: 702.
27. Hill OW, Monger RH. Undulant fever in a child under 7 months of age. JAMA 1931; 97: 176.
28. Kohlbry CO. Case of undulant fever in an infant. Minnesota Med 1929; 12: 414.
29. Smits HL, Kadri SM. Brucellosis in India: a deceptive infectious disease. Indian J Med Res; 2005:122:375-384
30. Al-Shamahy HA, Wright SG. Astudy of 235 cases of human brucellosis in Sana'a, Republic of Yemen. Eastern Mediterranean Health Journal 2001; 7: 238-246.
31.Sachdev A, Vohra R, Bijarnia S. Acute Brucellosis of Childhood:Acase Report with Unusual Features.Indian Pediatrics 2001; 38: 1421-1425
32. Ajlouni YM, Shaker K. The diagnostic value of various laboratory tests in human Brucellosis. Journal of the Royal Medical Services 1997; 4(2):9-12.
33. Giannakopoulos I, Nikolakopoulou NM, Eliopoulou M, Ellina A, Kolonitsiou F, Papanastasiou DA. Presentation of childhood brucellosis in Western Greece.Jpn J Infect Dis. 2006; 59(3):160-3.
34. Gotuzzo E, Carillo C. Brucella arthritis. In: Espinoza L, Goldberg D, Arnett F, Alarcon G (eds), Infections in theRheumatic Disease. Grune and Stratton, Orlando, 1988.
35. Center for Disease Control. Brucellosis Surveillance Annual Summary, 1975. Center for Disease Control, Atlanta 1976.
36. Simpson WM. The clinical picture of undulant fever. Ohio State Med J 1931; 27:21-7
37. Degoy A, Montenegro C, Clinica y evolutividad de la brucellosis infantil por melitensis en medio endemico. Rev Assoc Med Argent 1951; 65: 568-73.
38. Feiz J, Sabbaghian LT, Miralai M. Brucellosis due to B. melitensis in children. Clin Pediatr 1978; 17: 904-7.
39. Henk L, Kadri SM. Brucellosis. Indian Journal for the Practising Doctor 2004; 1:11-12.
40. Issa H, Jamal M. Brucellosis in children in south Jordan. Eastern Mediterranean Health Journal1999; 5:895-902.